Parent Resource6
Exercises and Assignments
Created August 14, 2009
Antibiotic Resistance and Dual Use

Added07/01/2010

Updated05/12/2016

Author(s) Daniel A. Vallero
Contributor(s) Daniel A. Vallero
Notes This material is based on a discussion in D.A. Vallero (2010). Environmental Biotechnology: A Biosystems Approach. Elsevier Academic Press, Amsterdam, The Netherlands. An annotated presentation entitled amp;quot;Humility and Hubris in Science: The Rewards and Risks of Emerging Technologiesamp;quot; serves as a companion presentation to this case. The presentation can be downloaded in either PDF or Power Point format.
Share with EEL Yes
Rights For more information on permissions to use this material please see: http://onlineethics.org/permissions.aspx
Year 2010
Publisher provided Keywords BIOLOGY Emerging Technologies humanities MEDICINE MILITARY ethics PHYSICS public safety SCIENCE
Language English

Search this Publication

Notes
  • 1.Federation of American Scientists (2009). Cases in Dual Use: Biological Research. http://www.fas.org/biosecurity/education/dualuse/; accessed on September 20, 2009.
  • 2.Ibid.
  • 3.R.A. Udani and S.B. Levy (2006). MarA-like regulator of multidrug resistance in Yersinia pestis. Antimicrobial Agents and Chemotherapy. 50 (9): 2971-2975.
  • 4.Federation of American Scientists (2009).
  • 5.Ibid.
  • 6.United Kingdom Department of Environment, Food, and Rural Affairs, Expert Panel on Air Quality Standards (2004). Airborne Particles: What Is the Appropriate Measurement on which to Base a Standard? A Discussion Document.
  • 7.Aerosol textbooks provide methods to determine the aerodynamic diameter of particles less than 0.5 micrometer. For larger particles gravitational settling is more important and the aerodynamic diameter is often used.
  • 8.American Lung Association (1978), Health Effects of Air Pollution. American Lung Association. New York, NY.
  • 9.Federation of American Scientists (2009). Aerosol Delivery Case Study. http://www.fas.org/biosecurity/education/dualuse/; accessed on September 20, 2009.
  • 10.D.A. Edwards, J. Hanes, G. Caponnetti, J. Hrkach, A. Ben-Jebria, M.-L. Eskew, J. Mintzes, D. Deaver, N. Lotan and R. Langer (1997). Large porous particles for pulmonary drug delivery. Science 276: 1868-1871.
  • 11.Federation of American Scientists (2009). Aerosol Delivery Case Study.
Cite this page: "Notes" Online Ethics Center for Engineering 7/1/2010 OEC Accessed: Wednesday, June 19, 2019 <www.onlineethics.org/Resources/TeachingTools/Exercises/DualUse/28698.aspx>